Healthcare Industry News: Zimmer
News Release - February 5, 2008
J. Raymond Elliott and Richard F. Wallman Join Bausch & Lomb Board of DirectorsROCHESTER, N.Y.--(HSMN NewsFeed)--Bausch & Lomb, the global eye health company, today announced that J. Raymond Elliott and Richard F. Wallman have joined its board of directors.
“Our board of directors is helping guide the company into an extended period of growth,” said Gerald M. Ostrov, board chairman and chief executive officer, Bausch & Lomb. “Ray and Richard further enhance the board’s expertise in global business expansion and healthcare markets. We look forward to benefiting from their insight and knowledge.”
Mr. Elliott served as chairman, president and chief executive officer of Zimmer Holdings, Inc. from 2001 until his retirement in 2007. Prior, Mr. Elliott spent almost 30 years in general management positions in the healthcare, media and consumer products industries. He began his career with American Hospital Supply Corporation, culminating in the role of president of the Far East divisions in Tokyo, Japan. Mr. Elliott recently joined the board of Boston Scientific Corporation. He holds a B.A. degree from the University of Western Ontario, Canada.
Mr. Wallman was senior vice president and chief financial officer of Honeywell International, Inc. from 1995 until his retirement in 2003. Prior, he was vice president and controller at IBM Corporation, and held leadership positions at Chrysler Corporation over the course of 14 years. He is a director of Ariba, Convergys, Hayes Lemmerz International, Lear Corporation, and Roper Industries. Mr. Wallman holds a B.S. degree in electrical engineering from Vanderbilt University and an M.B.A. from the University of Chicago.
Mr. Elliott and Mr. Wallman join board members Joseph P. Landy, Elizabeth H. Weatherman and Sean D. Carney, all managing directors of Warburg Pincus LLC, and D. Scott Mackesy, general partner, Welsh Carson Anderson & Stowe.
About Bausch & Lomb
Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y. With revenues in excess of $2 billion, it employs more than 13,000 people worldwide and its products are available in more than 100 countries. More information can be found at www.bausch.com.
Source: Bausch & Lomb
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsPolyActiva appoints Tracy Valorie, ophthalmic industry expert and former Bausch & Lomb executive, to its Board of Directors
Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics
Bausch & Lomb Launches Innovative Bausch & Lomb INFUSE(TM) Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses